Table 2.
Antimicrobial drug susceptibility profiles for the 17 VIM-1–IMP-45–CRPA strains from China*.
| Strains | MIC (μg/mL) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MEM | IMP | CAZ | TCC | FEP | AZT | AK | TOB | LEV | CIP | P/T | CZA | COL | SCF | FDC | |
| CJ01 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| CJ02 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| CJ03 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| CJ04 | >16 | >16 | >64 | >128 | >32 | 2 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 1 |
| CJ05 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.25 |
| CJ06 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.125 |
| CJ07 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| CJ08 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| CJ09 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| CJ10 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| CJ11 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| CJ12 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.06 |
| CJ13 | >16 | >16 | >64 | >128 | >32 | 16 | >64 | >16 | >8 | >4 | 64/4 | >128/4 | ≤0.5 | >64 | 0.125 |
| CJ14 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| CJ15 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| CJ16 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| CJ17 | >16 | >16 | >64 | >128 | >32 | >32 | >64 | >16 | >8 | >4 | >128/4 | >128/4 | ≤0.5 | >64 | 0.5 |
| ATCC 27853 | 0.5 | 2 | 2 | 16 | 2 | 2 | ≤2 | ≤1 | 1 | 0.5 | 1/4 | 0.5/4 | 2 | ≤8 | 0.125 |
* AK, amikacin; ATCC, American Type Culture Collection (https://www.atcc.org); AZT, aztreonam; CAZ, ceftazidime; CIP, ciprofloxacin; COL, colistin; CRPA, carbapenem-resistant Pseudomonas aeruginosa; CZA, ceftazidime/avibactam; FDC, cefiderocol; FEP, cefepime; IPM, imipenem; VIM, Verona integron-encoded metallo-β-lactamase; LEV, levofloxacin; MEM, meropenem; NA, not applicable; P/T, piperacillin/tazobactam; ST313, sequence type 313;SCF,cefoperazone/sulbactam; TOB, tobramycin; TCC, ticarcillin/clavulanic acid.